Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Humanigen Executes Licensing Agreement for Lenzilumab™ in COVID-19 with KPM Tech/Telcon RF Pharmaceutical for South Korea and the Philippines
Wednesday, November 04, 2020Humanigen Inc a clinical stage biopharmaceutical company focused on preventing and treating an immune hyperresponse called cytokine storm with its lead drug candidate lenzilumab announced the execution of its first licensing transaction in the AsiaP...
TFF Pharmaceuticals, Inc. and Augmenta Bioworks, Inc. Enter Into a Worldwide Joint Development Agreement for COVID-19 Monoclonal Antibody Therapies
Wednesday, November 04, 2020TFF Pharmaceuticals Inc a clinicalstage biopharmaceutical company and Augmenta Bioworks Inc a biotechnology company enabling breakthroughs in medicine through immune profiling today jointly announce that both companies have entered into a worldwide J...
CEPI Extends Partnership With Clover Biopharmaceuticals to Fund COVID-19 Vaccine Candidate Through Global Phase 2/3 Study to Licensure
Tuesday, November 03, 2020CEPI the Coalition for Epidemic Preparedness Innovations announced that it will fund the development of the proteinbased STrimer COVID vaccine candidate by Sichuan Clover Biopharmaceuticals Inc China Clover through a global pivotal Phase efficacy cl...
Zucara Therapeutics Expands ZT-01 Development Program to Type 2 Diabetes
Tuesday, November 03, 2020Zucara Therapeutics Inc a diabetes life sciences company developing the first oncedaily therapeutic to prevent insulininduced hypoglycemia low blood glucose levels today announced that it has expanded the development of ZT a somatostatin receptor an...
Telix Pharmaceuticals and China Grand Pharma Announce Strategic Licence and Commercial Partnership for Greater China Market
Monday, November 02, 2020Telix Pharmaceuticals Limited announces it has entered into a strategic licence and commercial partnership with China Grand Pharmaceutical and Healthcare Holdings Limited China Grand Pharma for Telixs portfolio of MolecularlyTargeted Radiation MTR pr...
Ocular Therapeutix™ and AffaMed Therapeutics Announce License Agreement and Collaboration for DEXTENZA® and OTX-TIC in Asia
Saturday, October 31, 2020Ocular Therapeutix Inc a biopharmaceutical company focused on the formulation development and commercialization of innovative therapies for diseases and conditions of the eye today announced a license agreement and a collaboration with AffaMed Therap...
Protagonist Therapeutics Announces Advancement of Oral IL-23 Receptor Antagonists Program in Collaboration with Janssen
Friday, October 30, 2020Protagonist Therapeutics Inc announced that two additional oral peptide IL receptor antagonist candidates from its collaboration agreement with Janssen Biotech Inc have been selected for advancement into clinical development
AbCellera and Kodiak Sciences Enter Second Antibody Discovery Collaboration for Ophthalmology Targets
Friday, October 30, 2020AbCellera and Kodiak Sciences Incannounced a new partnership to generate therapeutic antibody candidates in ophthalmology Following a previously successful collaboration AbCellera will use its full stack AIpowered antibody discovery technology to dis...
Releviate Therapeutics Inks Exclusive License for Human Monoclonal Antibodies for Chronic Pain Indications
Thursday, October 29, 2020Releviate Therapeutics a biopharmaceutical company addressing the needs of patients suffering from chronic pain signs an exclusive license for two patent pending human monoclonal antibodies developed by researchers at the University of California Riv...
Insitro Announces Five-Year Discovery Collaboration with Bristol Myers Squibb to Discover and Develop Novel Treatments
Thursday, October 29, 2020Insitro a machinelearning driven drug discovery and development company today announced that it has entered into a fiveyear discovery collaboration with Bristol Myers Squibb focused on the discovery and development of novel therapies for the treatmen...
